Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MEDICINOVA-INC-38688/news/MediciNova-Announces-Results-of-Subgroup-Analysis-from-the-SPRINT-MS-Phase-2b-Trial-of-MN-166-ibudi-28334394/?utm_source=whatsapp&utm_medium=social&utm_campaign=share